Tilray Brands announced an achievement in the medical cannabis industry in Portugal. Following the approval of our Tilray whole flower THC 18, Tilray Medical has now received approval for the first medical cannabis extract, Tilray Oral Solution THC 5 CBD 20, in Portugal. The newly approved medical cannabis extract is set to launch in late spring, offering new therapeutic options for patients across Portugal with specified medical conditions. The approved extract is indicated for use in several critical areas of patient care.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TLRY:
- Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal
- Tilray Wellness Introduces New Superfood Products Powered by Hemp at Expo West
- Tilray Introduces New Naturally Flavoured CBG Infused Cannabis Beverages
- Unusually active option classes on open March 8th
- Tilray (TSE:TLRY) Dips despite a New Product and Contest